Table 1 Identification of historical and policy cohorts: eligible, excluded, and included users of originator etanercept
Cohort, n (%) | ||||
|---|---|---|---|---|
Historical | Policy | |||
2016 | 2017 | 2018 | 2019 | |
Identification period | November 28, 2015 to May 26, 2016a | November 27, 2016 to May 26, 2017 | November 27, 2017 to May 26, 2018 | November 27, 2018 to May 26, 2019 |
Eligible prescriptions for originator etanercept (patients) during the identification period | 11,360 (2423) | 11,952 (2476) | 11,274 (2266) | 10,374 (2065) |
Exclusion criteria, number of patients excluded (% of patients identified)b | ||||
Diagnosis of psoriasis | 112 (4.6) | 88 (3.6) | 81 (3.6) | 69 (3.3) |
Low compliance/discontinuers | 283 (11.7) | 276 (11.1) | 245(10.8) | 220 (10.7) |
Switchers | 19 (0.8) | 22 (0.9) | 10 (0.4) | 8 (0.4) |
Short follow-up | 21 (0.9) | 20 (0.8) | 16 (0.7) | 12 (0.6) |
No PharmaCare coverage | 110 (4.5) | 107 (4.3) | 91 (4.0) | 62 (3.0) |
Final number of etanercept users included in the cohort | 1878 | 1963 | 1823 | 1694 |